Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Scientists show p300 protein may stop MDS from developing into leukemia

Scientists show p300 protein may stop MDS from developing into leukemia

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

Early death from pediatric cancer subtypes more likely to happen than previously reported

Early death from pediatric cancer subtypes more likely to happen than previously reported

Research findings could guide development of potent combination therapies for leukemia

Research findings could guide development of potent combination therapies for leukemia

Clinical study seeks to examine new combination therapy for treating AML patients

Clinical study seeks to examine new combination therapy for treating AML patients

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

New drug offers hope for patients with bladder cancer

New drug offers hope for patients with bladder cancer

Researchers develop computer machine-learning model to predict remission or relapse in AML patients

Researchers develop computer machine-learning model to predict remission or relapse in AML patients

Common drug for autoimmune disease may increase risk of myeloid neoplasms

Common drug for autoimmune disease may increase risk of myeloid neoplasms

Researchers design antibody that recognizes and destroys blood cancer stem cells

Researchers design antibody that recognizes and destroys blood cancer stem cells

Roswell Park study provides new insights into gene mutations that can lead to cancer

Roswell Park study provides new insights into gene mutations that can lead to cancer

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

Researchers identify possible treatment targets for myelodysplasia syndromes

Researchers identify possible treatment targets for myelodysplasia syndromes

UC researchers uncover obesity-related protein's role in leukemia development

UC researchers uncover obesity-related protein's role in leukemia development